CD79A and nasopharyngeal carcinoma: In the case of EBV DNA, the most specific assay with the highest positive predictive value was the combination of IgA-VCA and EBV DNA, but only 17 (53.1%) of the 32 VCA-negative patients with NPC had positive EBV DNA results (Figure 2E).